Evidence map›Paper›PMID 27048280›Full record

SynthesisBMC health services research2016

Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence.

Rachel Reilly, Katharine Evans, Judith Gomersall, Gillian Gorham, Micah D J Peters, Steven Warren, Rebekah O'Shea, Alan Cass, Alex Brown

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMC health services research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 10 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 10 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Rachel ReillyWardliparingga Aboriginal Research Unit, South Australian Health and Medical Research Institute, Adelaide, Australia. rachel.reilly@sahmri.com.
Katharine EvansMenzies School of Health Research, Darwin, Australia.
Judith GomersallWardliparingga Aboriginal Research Unit, South Australian Health and Medical Research Institute, Adelaide, Australia.
Gillian GorhamMenzies School of Health Research, Darwin, Australia.
Micah D J PetersJohanna Briggs Institute, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia.
Steven WarrenBaker IDI Heart and Diabetes Institute, Alice Springs, Australia.
Rebekah O'SheaWardliparingga Aboriginal Research Unit, South Australian Health and Medical Research Institute, Adelaide, Australia.
Alan CassMenzies School of Health Research, Darwin, Australia.
Alex BrownWardliparingga Aboriginal Research Unit, South Australian Health and Medical Research Institute, Adelaide, Australia.
Menzies School of Health Research · AUSouth Australian Health and Medical Research Institute · AUUniversity of Adelaide · AUBaker Heart and Diabetes Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndigenous peoples in Australia, New Zealand and Canada carry a greater burden of chronic kidney disease (CKD) than the general populations in each country, and this burden is predicted to increase. Given the human and economic cost of dialysis, understanding how to better manage CKD at earlier stages of disease progression is an important priority for practitioners and policy-makers. A systematic review of mixed evidence was undertaken to examine the evidence relating to the effectivness, cost-effectiveness and acceptability of chronic kidney disease management programs designed for Indigenous people, as well as barriers and enablers of implementation of such programs.

methodsPublished and unpublished studies reporting quantitative and qualitative data on health sector-led management programs and models of care explicitly designed to manage, slow progression or otherwise improve the lives of Indigenous people with CKD published between 2000 and 2014 were considered for inclusion. Data on clinical effectiveness, ability to self-manage, quality of life, acceptability, cost and cost-benefit, barriers and enablers of implementation were of interest. Quantitative data was summarized in narrative and tabular form and qualitative data was synthesized using the Joanna Briggs Institute meta-aggregation approach.

resultsTen studies were included. Six studies provided evidence of clinical effectiveness of CKD programs designed for Indigenous people, two provided evidence of cost and cost-effectiveness of a CKD program, and two provided qualitative evidence of barriers and enablers of implementation of effective and/or acceptable CKD management programs. Common features of effective and acceptable programs were integration within existing services, nurse-led care, intensive follow-up, provision of culturally-appropriate education, governance structures supporting community ownership, robust clinical systems supporting communication and a central role for Indigenous Health Workers.

conclusionsGiven the human cost of dialysis and the growing population of people living with CKD, there is an urgent need to draw lessons from the available evidence from this and other sources, including studies in the broader population, to better serve this population with programs that address the barriers to receiving high-quality care and improve quality of life.

Indexed as

Health Services, IndigenousPopulation GroupsPrimary Health CareAustraliaCanadaChronic DiseaseCost-Benefit AnalysisDisease ManagementDisease ProgressionHealth Knowledge, Attitudes, PracticeHealth PromotionHealth Services AccessibilityHumansNew ZealandPatient Acceptance of Health CareProgram Developmentchronic disease managementChronic kidney diseaseIndigenous healthsystematic review

Identifiers

PMID27048280
PMCPMC4822249
OpenAlexW2312300150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.